Case of Raynaud Syndrome after the Use of Methimazole

  • Kim Y
  • Tag H
  • Kim G
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Raynaud syndrome is a medical condition that causes pain, numbness, and changes in skin color at the distal extremities. Raynaud syndrome can be subdivided into primary Raynaud's and secondary Raynaud's. The former is diagnosed when the cause is unknown and the latter is caused by an underlying condition, such as connective tissue diseases, injury, smoking, or certain medications. Both cancer chemotherapy and beta-blockers are relatively common causes of Raynaud syndrome but there are no reports of its association with methimazole administration. The authors encountered a 43-year old woman with hyperthyroidism who developed digital ulcers associated with Raynaud syndrome after a methimazole treatment. Her digital ulcers and Raynaud syndrome were improved after methimazole was replaced with propylthiouracil and conventional therapy. This paper reports this case along with a review of the relevant literature.

Cite

CITATION STYLE

APA

Kim, Y., Tag, H.-S., Kim, G.-T., Lee, S.-G., Park, E.-K., Park, J.-H., … Kim, J.-H. (2018). Case of Raynaud Syndrome after the Use of Methimazole. Journal of Rheumatic Diseases, 25(3), 203. https://doi.org/10.4078/jrd.2018.25.3.203

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free